et al. Circulating tumor DNA as a clinical test in resected pancreatic cancer. Clin. Cancer Res. 25, 4973–4984 (2019). 29. Hussung, S. et al. Longitudinal analysis of cell-free mutated KRAS and CA 19–9 predicts survival following curative resection of pancreatic cancer. BMC Cancer 21, 49 (2021). 30. Łuksza, M. et al. A neoantigen fitness model predicts tumour response to checkpoint blockade immunotherapy. Nature 551, 517–520 (2017).